# Thermo Fisher Scientific to acquire Qiagen for $11.5 billion

Thermo Fisher Scientific announced a proposal to acquire Qiagen for €39 per share in cash, valuing the transaction at approximately $11.5 billion including assumed debt.

- Type: Acquisition
- Announced: 2020-03-03
- Value: $11.5B
- Status: announced
- Products: molecular diagnostics, sample preparation technologies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Thermo Fisher Scientific](https://endata.com/companies/7061.md) (acquirer)
- [Qiagen](https://endata.com/companies/34370.md) (target)

## Sources

- [clpmag.com](https://clpmag.com/lab-management/company-news/thermo-fisher-scientific-to-acquire-qiagen/), 2020-03-03: "Thermo Fisher Scientific, Waltham, Mass, a world leader in serving science, and Qiagen, Venlo, the Netherlands, a leading global provider of molecular diagnostics and sample preparation technologies, today announced that their boards of directors, as well as the managing board of Qiagen, have unanim"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.